Farmers Trust Co. buy 258 shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

VaselineOctober 5, 2024

0 5 minutes read

Farmers Trust Co. increased its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 70.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 622 shares of the medical research company’s stock after acquiring an additional 258 shares during the period. Farmers Trust Co holdings. holdings in Thermo Fisher Scientific were worth $385,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have recently made changes to their positions in TMO. Signature Resources Capital Management LLC raised its position in Thermo Fisher Scientific by 318.2% during the 2nd quarter. Signature Resources Capital Management LLC now owns 46 shares of the medical research company’s stock worth $25,000 after acquiring an additional 35 shares in the last quarter. True Wealth Design LLC boosted its holdings in shares of Thermo Fisher Scientific by 1,275.0% during the fourth quarter. True Wealth Design LLC now owns 55 shares of the medical research company’s stock worth $29,000 after purchasing an additional 51 shares during the period. New Millennium Group LLC bought a new position in Thermo Fisher Scientific in the second quarter worth $29,000. Stephens Consulting LLC increased its position in shares of Thermo Fisher Scientific by 116.0% during the second quarter. Stephens Consulting LLC now owns 54 shares of the medical research company’s stock worth $30,000 after acquiring an additional 29 shares in the last quarter. Finally, LifeSteps Financial Inc. purchased a new stake in shares of Thermo Fisher Scientific in the first quarter worth $31,000. Institutional investors own 89.23% of the company’s shares.

Indoor activity

In other Thermo Fisher Scientific news, CAO Joseph R. Holmes sold 860 shares of the business’s stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $611.03, for a total value of $525,485.80. Following the completion of the sale, the chief accounting officer now owns 1,814 shares in the company, valued at $1,108,408.42. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC’s website. In other Thermo Fisher Scientific news, SVP Michael A. Boxer sold 2,000 shares of the stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $600.85, for a total value of $1,201,700.00. Following the completion of the sale, the senior vice president now owns 13,083 shares in the company, valued at approximately $7,860,920.55. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CAO Joseph R. Holmes sold 860 shares of the business’s stock in a transaction that occurred on Friday, July 26th. The shares were sold at an average price of $611.03, for a total value of $525,485.80. Following the transaction, the chief accounting officer now owns 1,814 shares of the company’s stock, valued at approximately $1,108,408.42. The disclosure for this sale can be found here. Over the last three months, insiders have sold 23,084 shares of company stock worth $14,094,292. 0.34% of shares are currently owned by insiders.

Changes in Analyst Ratings

Want more great investment ideas?

TMO has been the subject of several recent analyst reports. Barclays decreased their price objective on Thermo Fisher Scientific from $615.00 to $600.00 and set an “equal weight” rating on the stock in a research note on Friday, June 28th. Wells Fargo & Company began coverage on Thermo Fisher Scientific in a report on Tuesday, August 27th. They issued an “overweight” rating and a $670.00 price target on the stock. JPMorgan Chase & Co. boosted their target price on shares of Thermo Fisher Scientific from $650.00 to $670.00 and gave the stock an “overweight” rating in a report on Friday, September 20th. Robert W. Baird lifted their price target on Thermo Fisher Scientific from $620.00 to $632.00 and gave the company an “outperform” rating in a research report on Thursday, July 25th. Finally, Stifel Nicolaus upped their target price on shares of Thermo Fisher Scientific from $615.00 to $680.00 and gave the company a “buy” rating in a research report on Friday, September 20th . Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Moderate Buy” and a consensus price target of $653.72, according to MarketBeat.com.

Check out our latest report on Thermo Fisher Scientific

Thermo Fisher Scientific trades down 1.9%

Shares of TMO stock opened at $600.92 on Friday. The company’s 50-day simple moving average is $609.63, and its 200-day simple moving average is $582.66. The company has a market cap of $229.55 billion, a P/E ratio of 38.55, a P/E/G ratio of 3.90 and a beta of 0.78. Thermo Fisher Scientific Inc. has a 1 year low of $415.60 and a 1 year high of $627.88. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.72, and a quick ratio of 1.37.

Thermo Fisher Scientific (NYSE:TMO – Get Free Report ) last posted its quarterly earnings results on Wednesday, July 24th. The medical research company reported $5.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.13 by $0.24. The firm had revenue of $10.54 billion during the quarter, compared to analyst estimates of $10.50 billion. Thermo Fisher Scientific had a return on equity of 18.22% and a net margin of 14.69%. The company’s revenue was down 1.4% compared to the same quarter last year. In the same quarter last year, the company posted earnings of $5.15 per share. Sell-side analysts estimate that Thermo Fisher Scientific Inc. will post 21.72 earnings per share for the current fiscal year.

Thermo Fisher Scientific announces dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Friday, September 13th will be given a $0.39 dividend. This represents an annualized dividend of $1.56 and a yield of 0.26%. The ex-dividend date of this dividend is Friday, September 13. Thermo Fisher Scientific’s dividend payout ratio is currently 10.01%.

About Thermo Fisher Scientific

(Free report)

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics and laboratory products and biopharmaceutical services in North America, Europe, Asia-Pacific and internationally. The company’s Life Sciences Solutions segment provides reagents, instruments and supplies for biological and medical research, drug and vaccine discovery and production, and infection and disease diagnosis; and solutions include biosciences, genetic sciences and biological manufacturing for the pharmaceutical, biotech, agricultural, clinical, healthcare, academic and government markets.